Cargando…
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359627/ https://www.ncbi.nlm.nih.gov/pubmed/34385600 http://dx.doi.org/10.1038/s41380-021-01254-3 |
| _version_ | 1783737586916786176 |
|---|---|
| author | Hoertel, Nicolas Sánchez-Rico, Marina Cougoule, Céline Gulbins, Erich Kornhuber, Johannes Carpinteiro, Alexander Becker, Katrin Anne Reiersen, Angela M. Lenze, Eric J. Seftel, David Lemogne, Cédric Limosin, Frédéric |
| author_facet | Hoertel, Nicolas Sánchez-Rico, Marina Cougoule, Céline Gulbins, Erich Kornhuber, Johannes Carpinteiro, Alexander Becker, Katrin Anne Reiersen, Angela M. Lenze, Eric J. Seftel, David Lemogne, Cédric Limosin, Frédéric |
| author_sort | Hoertel, Nicolas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8359627 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83596272021-08-13 Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms Hoertel, Nicolas Sánchez-Rico, Marina Cougoule, Céline Gulbins, Erich Kornhuber, Johannes Carpinteiro, Alexander Becker, Katrin Anne Reiersen, Angela M. Lenze, Eric J. Seftel, David Lemogne, Cédric Limosin, Frédéric Mol Psychiatry Correspondence Nature Publishing Group UK 2021-08-12 2021 /pmc/articles/PMC8359627/ /pubmed/34385600 http://dx.doi.org/10.1038/s41380-021-01254-3 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Hoertel, Nicolas Sánchez-Rico, Marina Cougoule, Céline Gulbins, Erich Kornhuber, Johannes Carpinteiro, Alexander Becker, Katrin Anne Reiersen, Angela M. Lenze, Eric J. Seftel, David Lemogne, Cédric Limosin, Frédéric Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms |
| title | Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms |
| title_full | Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms |
| title_fullStr | Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms |
| title_full_unstemmed | Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms |
| title_short | Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms |
| title_sort | repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against covid-19: current evidence and potential mechanisms |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359627/ https://www.ncbi.nlm.nih.gov/pubmed/34385600 http://dx.doi.org/10.1038/s41380-021-01254-3 |
| work_keys_str_mv | AT hoertelnicolas repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT sanchezricomarina repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT cougouleceline repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT gulbinserich repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT kornhuberjohannes repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT carpinteiroalexander repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT beckerkatrinanne repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT reiersenangelam repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT lenzeericj repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT sefteldavid repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT lemognecedric repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms AT limosinfrederic repurposingantidepressantsinhibitingthesphingomyelinaseacidceramidesystemagainstcovid19currentevidenceandpotentialmechanisms |